Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-06-13
2010-10-26
Huff, Sheela J (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100
Reexamination Certificate
active
07820400
ABSTRACT:
The present invention provides monoclonal antibody-producing hybridomas designated 27.F7 and 27.B1. The invention provides a method of detecting TIP-2 antigen bearing cancer cells in a sample. The invention provides a method of detecting TIP-2 antigen on the surface of cancer cells. The invention provides a method for diagnosing cancer in a subject. The invention provides a method for delivering exogenous material to TIP-2 antigen-bearing cancer cells of a human subject. The invention provides a method for treating cancer in a human subject. The invention provides isolated peptides having the amino acid sequences Lys Leu Leu Gly Gly Gln Ile Gly Leu (SEQ. ID No.) and Ser Leu Leu Gly Cys Arg His Tyr Glu Val (SEQ. ID No.). The invention provides a method for immunohistochemical screening of a tissue section for the presence of TIP-2 antigen bearing cancer cells. The invention provides a kit for detecting the presence of TIP-2 antigen-bearing cancer cells. The invention provides a method for detecting the presence of TIP-2 antigen. The invention provides a method for immunohistochemical screening of tissue sections. The invention provides a method for monitoring progression of cancer wherein the cancer cells are TIP-2 antigen-bearing cells. The invention provides a method for diagnosing cancer associated with the expression of TIP-2.
REFERENCES:
patent: 4281061 (1981-07-01), Zuk et al.
patent: 4574116 (1986-03-01), Kaplan et al.
patent: 4613576 (1986-09-01), Cote et al.
patent: 4618577 (1986-10-01), Handley et al.
patent: 4634664 (1987-01-01), Oestberg
patent: 4634666 (1987-01-01), Engleman et al.
patent: 4668629 (1987-05-01), Kaplan et al.
patent: 4689299 (1987-08-01), Insel et al.
patent: 4714681 (1987-12-01), Reading et al.
patent: 4720459 (1988-01-01), Winkelhake
patent: 4744982 (1988-05-01), Hunter et al.
patent: 4761377 (1988-08-01), Glassy et al.
patent: 4800155 (1989-01-01), Taniguchi et al.
patent: 4834976 (1989-05-01), Rosok et al.
patent: 4916072 (1990-04-01), Tsuji et al.
patent: 4950595 (1990-08-01), Masuho et al.
patent: 4954449 (1990-09-01), Hunter et al.
patent: 4997762 (1991-03-01), Hanna, Jr. et al.
patent: 5001065 (1991-03-01), Larrick et al.
patent: 5003046 (1991-03-01), Neville et al.
patent: 5006470 (1991-04-01), Yamaguchi et al.
patent: 5093261 (1992-03-01), Hagiwara et al.
patent: 5126259 (1992-06-01), Tada et al.
patent: 5196337 (1993-03-01), Ochi et al.
patent: 5215913 (1993-06-01), Posner
patent: 5252480 (1993-10-01), Yokota et al.
patent: 5298419 (1994-03-01), Masuho et al.
patent: 5426046 (1995-06-01), Kaplan et al.
patent: 5459060 (1995-10-01), Cotropia
patent: 5506132 (1996-04-01), Lake et al.
patent: 5565354 (1996-10-01), Ostberg
patent: 5576184 (1996-11-01), Better et al.
patent: 5652114 (1997-07-01), Chu et al.
patent: 5879936 (1999-03-01), Bebbington et al.
patent: 6197582 (2001-03-01), Trakht
patent: 6368826 (2002-04-01), Ligensa et al.
patent: 6455040 (2002-09-01), Wei et al.
patent: 6913883 (2005-07-01), Ligensa et al.
patent: 7060802 (2006-06-01), Trakht et al.
patent: 2002/0146728 (2002-10-01), Ligensa et al.
patent: 2007/0082382 (2007-04-01), Trakht
patent: 0 137 234 (1985-04-01), None
patent: 0 695 760 (1996-02-01), None
patent: 0 799 836 (1997-10-01), None
patent: 1 006 184 (2000-06-01), None
patent: WO 91/09967 (1991-04-01), None
patent: WO 94/27638 (1994-12-01), None
patent: WO 99/47929 (1999-09-01), None
patent: WO 00/69898 (2000-11-01), None
Campbell, Monoclonal Antibody technology, Chapter 1, pp. 1-32 (1984).
Yolken Infectious Diseases vol. 4 p. 35-68 (1982).
Antonov AS, Nikolaeva MA. Klueva TS, Romanov YA, Babaev VR, Bystrevskaya VB, Perov NA, Repin VS, Smirnov VN (1986) Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulations. Atherosclerosis 59:1-19.
Berman DM, Gilman AG (1998) Mammalian RGS proteins: barbarians at the gate. J Biol Chem 273:1269-1272.
Borrebaeck CA, Danielsson L, Moller SA (1987) Human monoclonal antibodies produced from L-leucine methyl ester-treated and in vitro immunized peripheral blood lymphocytes. Biochem Biophys Res Commun 148:941-946.
Brodin T, Olsson L, Sjogren HO (1983) Cloning of human hybridoma, myeloma, and lymphoma cell lines using enriched human monocytes as feeder layer. J Immunol Methods 60:1-7.
Casali P et al. (1986) Science 234:476-479.
Campbell AM (1986) Monoclonal Antibody Technology. Elsevier Publishing Co., New York, pp. 1-32.
De Vrise et al. (1998) PNAS 95:12340-45.
Galanos G et al. (1969) Eur J Biochem 9:245-249.
Glassy MC, Handley HH, Hagiwara H, Royston I (1983) UC 729-6, a human lymphoblasted B-cell line useful for generating antibody-secreting human-human hybridomas. Proc Natl Acad Sci (USA) 80:6327-6331.
Goldman-Leikin RE, Salwen HR, Herst CV, Variakojis D, Bian ML et al. (1989) Characterization of a novel myeloma cell line, MM.1. J Lab Clin Med 113:335-345.
Green et al (1994) Nature Genetics 7:13.
Greenspan et al (1999) Nature Biotechnology 17:936-37.
Harlow et al (1988) Antibodies, A laboratory manual, Cold Spring Harbor Laboratory, p. 319 and 322, 198.
Kalantarov GF, Rudchenko SA, Lobel LI, Trakht I (2002) Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes. Hum. Antibodies 11(3): 85-96.
Kennedy MB (1995) Origin of ODZ (DHR, GLGF) domains. Trends Biochem Sci 20:350.
Kirman I, Kalantarov GF, Lobel LI, Hibshoosh H, Estabrook A, Canfield R, Trakht I. (2002) Isolation of native human monoclonal autoantibodies to breast cancer. Hybrid Hybridomics 21(6):405-414.
Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
Kozbor D, Roder J (1981) Requirements for the establishment of high-titered monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. J Immunol 127:1275-1280.
Kozbor D, Tripputi P, Roder JC, Croce CM (1984) A human hybrid myelome for production of human monoclonal antibodies. J Immunol 133: 3001-3005.
Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibasahi M (1997) Binding of high risk papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci (USA) 94:11612-11616.
Lee SS, Weiss RS, Javier RT (1997) Binding of human virus oncoproteins to hd1g/SAP97, a mammalian homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci (USA) 94:6670-6675.
Levy R, Miller RA (1983) Tumor therapy with monoclonal antibodies. Fed Proc 42: 2650-2656.
Nilsson K, Ponten J 91975) Classification and biological nature of established human hematopoetic cell lines. Int J Cancer 15:321-34.
Olsson L, Kronstrom H, Cambon-De Mouzon A, Honsik C, Brodin T, Jakobsen B (1983) Antibody producing human-human hybridomas. I. Technical aspects. J Immunol Methods 61: 17-32.
Östberg L, Pursch E (1983) Human X (mouse X human) hybridomas stably producing himan antibodies. Hybridoma 2:361-367.
Paul (1993) Fundamental Immunology, Raven press, chapter 8, p. 242.
Posner MR, Schlossman SF, Lazarus H (1983) Novel approach to construction of human “myeloma analogues” for production of human monoclonal antibodies. Hybridoma 2:369-381.
Raison RL, Walker KZ, Halnan CR, Briscoe D, Basten A. (1982) Loss of secretion in mouse-human hybrids need not be due to the loss of a structural gene. J Exp. Med 156:1380-1389.
Reading CL (1982) Theory and methods for immunization in culture and monoclonal antibody production. J. Immunol Methods 53: 261-291.
Rousset et al (1998) Oncogene 16:643-54.
Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schbert I, Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci (USA) 92: 11810-11813.
Saras J, Heldin CH (1996) PDZ domains bind carboxy-terminal sequences of target proteins. Trends Biochem Sci 21:455-458.
Scanlan MJ, Chen Y-T, Williamson B, Gure AO, Stockert JD, Gordon O,
Canfield Robert
Kalantarov Gary
Rudchenko Sergei
Trakht Ilya
Cooper & Dunham LLP
Huff Sheela J
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Tumor-associated marker does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor-associated marker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor-associated marker will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4189505